BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 29183246)

  • 1. Uptake trends in the Scottish Bowel Screening Programme and the influences of age, sex, and deprivation.
    Quyn AJ; Fraser CG; Stanners G; Carey FA; Carden C; Shaukat A; Steele RJ
    J Med Screen; 2018 Mar; 25(1):24-31. PubMed ID: 29183246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Faecal haemoglobin distributions by sex, age, deprivation and geographical region: consequences for colorectal cancer screening strategies.
    Clark GRC; Strachan JA; McPherson A; Digby J; Mowat C; Steele RJC; Fraser CG
    Clin Chem Lab Med; 2020 Nov; 58(12):2073-2080. PubMed ID: 32324157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized controlled trial: Flexible sigmoidoscopy as an adjunct to faecal occult blood testing in population screening.
    Steele RJ; Carey FA; Stanners G; Lang J; Brand J; Brownlee LA; Crichton EM; Winter JW; Phull PS; Mowat C; Strachan JA; Digan AM; Fraser CG
    J Med Screen; 2020 Jun; 27(2):59-67. PubMed ID: 31690179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of area-level deprivation and gender in participation in population-based faecal immunochemical test (FIT) colorectal cancer screening.
    Clarke N; McNamara D; Kearney PM; O'Morain CA; Shearer N; Sharp L
    Prev Med; 2016 Dec; 93():198-203. PubMed ID: 27765660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of evidence-based strategies to reduce the socioeconomic gradient of uptake in the English NHS Bowel Cancer Screening Programme (ASCEND): four cluster-randomised controlled trials.
    Wardle J; von Wagner C; Kralj-Hans I; Halloran SP; Smith SG; McGregor LM; Vart G; Howe R; Snowball J; Handley G; Logan RF; Rainbow S; Smith S; Thomas MC; Counsell N; Morris S; Duffy SW; Hackshaw A; Moss S; Atkin W; Raine R
    Lancet; 2016 Feb; 387(10020):751-9. PubMed ID: 26680217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colorectal cancer screening uptake over three biennial invitation rounds in the English bowel cancer screening programme.
    Lo SH; Halloran S; Snowball J; Seaman H; Wardle J; von Wagner C
    Gut; 2015 Feb; 64(2):282-91. PubMed ID: 24812001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inequalities in participation in an organized national colorectal cancer screening programme: results from the first 2.6 million invitations in England.
    von Wagner C; Baio G; Raine R; Snowball J; Morris S; Atkin W; Obichere A; Handley G; Logan RF; Rainbow S; Smith S; Halloran S; Wardle J
    Int J Epidemiol; 2011 Jun; 40(3):712-8. PubMed ID: 21330344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance measures in three rounds of the English bowel cancer screening pilot.
    Moss SM; Campbell C; Melia J; Coleman D; Smith S; Parker R; Ramsell P; Patnick J; Weller DP
    Gut; 2012 Jan; 61(1):101-7. PubMed ID: 21561880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased uptake and improved outcomes of bowel cancer screening with a faecal immunochemical test: results from a pilot study within the national screening programme in England.
    Moss S; Mathews C; Day TJ; Smith S; Seaman HE; Snowball J; Halloran SP
    Gut; 2017 Sep; 66(9):1631-1644. PubMed ID: 27267903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of gender, age and deprivation on key performance indicators in a FOBT-based colorectal screening programme.
    Steele RJ; Kostourou I; McClements P; Watling C; Libby G; Weller D; Brewster DH; Black R; Carey FA; Fraser C
    J Med Screen; 2010; 17(2):68-74. PubMed ID: 20660434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Faecal occult blood screening: knowledge, attitudes, and practice in four Hong Kong primary care clinics.
    Tam TK; Ng KK; Lau CM; Lai TC; Lai WY; Tsang LC
    Hong Kong Med J; 2011 Oct; 17(5):350-7. PubMed ID: 21979470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of repeated invitations on uptake of colorectal cancer screening using faecal occult blood testing: analysis of prevalence and incidence screening.
    Steele RJ; Kostourou I; McClements P; Watling C; Libby G; Weller D; Brewster DH; Black R; Carey FA; Fraser C
    BMJ; 2010 Oct; 341():c5531. PubMed ID: 20980376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre-notification increases uptake of colorectal cancer screening in all demographic groups: a randomized controlled trial.
    Libby G; Bray J; Champion J; Brownlee LA; Birrell J; Gorman DR; Crighton EM; Fraser CG; Steele RJ
    J Med Screen; 2011; 18(1):24-9. PubMed ID: 21536813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of a faecal immunochemical test narrows current gaps in uptake for sex, age and deprivation in a bowel cancer screening programme.
    Digby J; McDonald PJ; Strachan JA; Libby G; Steele RJ; Fraser CG
    J Med Screen; 2013 Jun; 20(2):80-5. PubMed ID: 24009088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of age, sex and socioeconomic deprivation on outcomes in a colorectal cancer screening programme.
    Mansouri D; McMillan DC; Grant Y; Crighton EM; Horgan PG
    PLoS One; 2013; 8(6):e66063. PubMed ID: 23776606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uptake of a colorectal cancer screening blood test in people with elevated risk for cancer who cannot or will not complete a faecal occult blood test.
    Symonds EL; Cock C; Meng R; Cole SR; Fraser RJL; Young GP
    Eur J Cancer Prev; 2018 Sep; 27(5):425-432. PubMed ID: 28368949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reducing the socioeconomic gradient in uptake of the NHS bowel cancer screening Programme using a simplified supplementary information leaflet: a cluster-randomised trial.
    Smith SG; Wardle J; Atkin W; Raine R; McGregor LM; Vart G; Morris S; Duffy SW; Moss S; Hackshaw A; Halloran S; Kralj-Hans I; Howe R; Snowball J; Handley G; Logan RF; Rainbow S; Smith S; Thomas M; Counsell N; von Wagner C
    BMC Cancer; 2017 Aug; 17(1):543. PubMed ID: 28806955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Socioeconomic variation in uptake of colonoscopy following a positive faecal occult blood test result: a retrospective analysis of the NHS Bowel Cancer Screening Programme.
    Morris S; Baio G; Kendall E; von Wagner C; Wardle J; Atkin W; Halloran SP; Handley G; Logan RF; Obichere A; Rainbow S; Smith S; Snowball J; Raine R
    Br J Cancer; 2012 Aug; 107(5):765-71. PubMed ID: 22864455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of the faecal immunochemical test at a range of positivity thresholds compared with the guaiac faecal occult blood test in the NHS Bowel Cancer Screening Programme in England.
    Murphy J; Halloran S; Gray A
    BMJ Open; 2017 Oct; 7(10):e017186. PubMed ID: 29079605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between socioeconomic deprivation and colorectal cancer screening outcomes: Low uptake rates among the most and least deprived people.
    Buron A; Auge JM; Sala M; Román M; Castells A; Macià F; Comas M; Guiriguet C; Bessa X; Castells X;
    PLoS One; 2017; 12(6):e0179864. PubMed ID: 28622365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.